This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Presented: European Congress of Pathology 2023
Study objective: To assess a clinically deployed artificial intelligence (AI) decision support solution for prostate biopsies, which was previously validated at UPMC1, in primary diagnosis employed in a digital pathology workflow.
Conclusions:
- Successful implementation of a multi-feature AI solution that automatically imparts clinically relevant diagnostic parameters regarding prostate cancer, grading, measurements, and other pathologic features at UPMC
- The solution demonstrated high accuracy for prostate cancer detection and improved diagnostic quality
- All pathologists feel confident in providing accurate diagnoses when reporting slides supported by Galen Prostate
- In the near future, AI and Digital Pathology will enable UPMC to implement a Centralized Laboratory approach
Click here to download the study:
Back